Efficacy and safety of cross-linked acellular porcine corneal stroma for infectious corneal disease in China: a multicenter prospective clinical trial

医学 眼科 角膜移植 视力 不利影响 移植 临床试验 角膜 外科 前瞻性队列研究 相伴的 内科学
作者
Yunxiao Zang,Lei Tian,Liya Wang,Yueqin Zhang,Lulu Wang,Ting C. Huang,Xiaojuan Dong,Jing Wu,Chaoran Zhang,Jianjiang Xu,Xipeng Guan,Xingxia Zhong,Lei Zhang,Ying Jie
出处
期刊:International Journal of Surgery [Wolters Kluwer]
卷期号:111 (12): 9271-9284 被引量:2
标识
DOI:10.1097/js9.0000000000003082
摘要

BACKGROUND: Acellular porcine corneal stroma (APCS) is a promising alternative to allografts; however, its potential requires verification. To evaluate the efficacy and safety of novel cross-linked APCS transplantation for the treatment of infectious corneal disease. METHODS: This prospective, multicenter, single-arm clinical trial was conducted from 2015-2019. Ninety patients with infectious corneal disease who had undergone anterior lamellar transplantation with an APCS across four centers in China were enrolled. All patients had previously received ineffective drug treatment and had a preoperative best-corrected visual acuity (BCVA) < 20/400. The primary outcome was the deblinding rate at 180 days compared to the target rate of 65%. The secondary outcomes included BCVA, corneal transparency, and epithelial healing. Safety endpoints included corneal graft rejection, blood count, liver and kidney function, immunoglobulin levels, concomitant medications, and additional treatments. Follow-up was performed for at least 6 months postoperatively. RESULTS: A total of 100% (90/90) and 88.9% (80/90) of the cases were included in the safety analysis and efficacy per protocol sets, respectively. Eighty percent (72/90) of patients completed 180 days of follow-up after APCS transplantation. The deblinding rate at 180 days was 90.3% (95% confidence interval 81-96%), exceeding the target ( P < 0.001). At 180 days, 55% of the grafts were completely transparent and 82.5% of the epithelium had no defects. The log of the minimum angle of resolution vision improved from 2.19 ± 0.25 preoperatively to 1.10 ± 0.3. No serious adverse events occurred. CONCLUSION: APCS demonstrated excellent corneal transparency and epithelialization following keratoplasty, confirming its safety and efficacy. Six-month data suggest its potential as an alternative treatment for infectious corneal disease. Further long-term trials are necessary to establish its comparative effectiveness and evaluate chronic complications, offering valuable insights for future clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI65的应助被卓卓卓采纳,获得10
刚刚
ouoii3完成签到,获得积分10
刚刚
正直无极完成签到,获得积分10
2秒前
heeh发布了新的文献求助10
3秒前
乐鱼发布了新的文献求助10
3秒前
张莹发布了新的文献求助30
3秒前
3秒前
double_manager的应助被Gxt采纳,获得10
3秒前
zyy发布了新的文献求助10
4秒前
4秒前
zan12131发布了新的文献求助30
4秒前
义气傲薇发布了新的文献求助10
5秒前
6秒前
6秒前
helping完成签到 ,获得积分10
6秒前
苏邑发布了新的文献求助10
6秒前
长风赴宴完成签到 ,获得积分10
6秒前
6秒前
6秒前
甜蜜发带完成签到 ,获得积分0
6秒前
7秒前
11完成签到,获得积分10
7秒前
酷炫师发布了新的文献求助10
7秒前
7秒前
Lucas的应助被Humingyu采纳,获得10
7秒前
9秒前
9秒前
Nia发布了新的文献求助10
9秒前
简单山水发布了新的文献求助10
9秒前
小孙大王发布了新的文献求助10
10秒前
10秒前
10秒前
踏实初蓝完成签到,获得积分20
10秒前
科研岗完成签到,获得积分10
10秒前
11秒前
唐唐发布了新的文献求助10
11秒前
xhy完成签到 ,获得积分10
11秒前
ini发布了新的文献求助10
11秒前
yan完成签到,获得积分10
11秒前
风_Feng完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181379
求助须知:如何正确求助?哪些是违规求助? 9571317
关于积分的说明 21817457
捐赠科研通 7777820
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479523